New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
Pharm Exec’s 21st Annual Pipeline Report examines emerging drug development classes, treatment modalities, and expansion pursuits in five therapeutic settings ripe for next-gen innovation.
MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases - A Market Projected to Exceed $120 billion by 2030 ...
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the ...
Researchers have developed a highly sensitive light-based sensor that can detect extremely low concentrations of cancer biomarkers in the blood. The new technology could one day make it possible to ...
Eicke Latz studied medicine at the Georg-August University in Göttingen and the Freie Universität Berlin, following which, he worked as an intensive care physician at the Charité Universitätsmedizin.
The currents of the oceans, the roiling surface of the sun, and the clouds of smoke billowing off a forest fire—all are ...
At this time, I'd like to turn the call over to your host, Eugene Fedotoff, IPG Photonics Corporation Senior Director, ...
President Ramaphosa confirmed plans for high-speed rail linking Durban and Johannesburg, signalling a shift in long-distance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results